Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

AIMS: As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Heart J
Main Authors: Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B., Brunner, Fabian J., Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M., Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G., Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Meta-Analysis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837491/
https://ncbi.nlm.nih.gov/pubmed/28449027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx166
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares